Texas Capital Bancshares Inc/Tx (TCBIO) Cash & Equivalents (2010 - 2019)

Texas Capital Bancshares (TCBIO) has reported Cash & Equivalents for 6 consecutive years, with $71.5 million the latest figure, recorded in Q4 2019.

• Quarterly Cash & Equivalents fell 20.21% year-over-year to $71.5 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $71.5 million (down 20.21% YoY) and the FY2019 annual result came in at $71.5 million, down 20.21% from the prior year.
• Cash & Equivalents slipped to $71.5 million in Q4 2019 per TCBIO's latest filing, from $89.6 million in the prior quarter.
• Over the last five years, Cash & Equivalents for TCBIO reached as high as $89.6 million in Q4 2018 and fell as low as $71.5 million in Q4 2019.